Business Daily.
.
The Times Real Estate
A+ R A-

Sedia Biosciences Expands Its HIV-1 LAg-Avidity Assay for Recent HIV-1 Infections to Dried Blood Spot Specimens

E-mail Print PDF
PORTLAND, Ore.--(BUSINESS WIRE)--Sedia Biosciences announces availability of a dried blood spot version of its HIV-1 LAg-Avidity Assay, which enables use in remote regions lacking a cold chain storage to measure disease incidence.

imageimage
Business Daily Media